AAAAAA
Results: 26-45/45
Authors:
Cotte, N
Balestre, MN
Aumelas, A
Mahe, E
Phalipou, S
Morin, D
Hibert, M
Manning, M
Durroux, T
Barberis, C
Mouillac, B
Citation: N. Cotte et al., Conserved aromatic residues in the transmembrane region VI of the V-1a vasopressin receptor differentiate agonist vs. antagonist ligand binding, EUR J BIOCH, 267(13), 2000, pp. 4253-4263
Authors:
Morin, D
Citation: D. Morin, Life after a value-for-money audit: The viewpoint of management, CAN PUBL AD, 43(4), 2000, pp. 432-452
Authors:
Corriveau, L
Morin, D
Citation: L. Corriveau et D. Morin, Modelling 3D architecture of western Grenville from surface geology, xenoliths, styles of magma emplacement, and Lithoprobe reflectors, CAN J EARTH, 37(2), 2000, pp. 235-251
Authors:
Morin, D
Sapena, R
Elimadi, A
Testa, B
Labidalle, S
Le Ridant, A
Tillement, JP
Citation: D. Morin et al., [H-3]-Trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance, BR J PHARM, 130(3), 2000, pp. 655-663
Authors:
Mayer, T
Snodgrass, WJ
Morin, D
Citation: T. Mayer et al., Spatial characterization of the occurrence of road salts and their environmental concentrations as chlorides in Canadian surface waters and benthic sediments, WAT QUAL RE, 34(4), 1999, pp. 545-574
Authors:
Lopez, C
Deschamps, F
Morin, D
Averous, M
Citation: C. Lopez et al., Antenatal diagnosis of bilateral polycystic kidney disease in a twin pregnancy., PROG UROL, 9(3), 1999, pp. 518-521
Authors:
Settaf, A
Morin, D
Lamchouri, F
Elimadi, A
Cherrah, Y
Tillement, JP
Citation: A. Settaf et al., Trimetazidine ameliorates the hepatic injury associated with ischaemia-reperfusion in rats, PHARMAC RES, 39(3), 1999, pp. 211-216
Authors:
Morin, D
Veyrac, C
Kotzki, PO
Lopez, C
Dalla Vale, F
Durand, MF
Astruc, J
Dumas, R
Citation: D. Morin et al., Comparison of ultrasound and dimercaptosuccinic acid scintigraphy changes in acute pyelonephritis, PED NEPHROL, 13(3), 1999, pp. 219-222
Authors:
Ichay, L
Morin, D
Dalla-Vale, F
Alba, M
Garabedian, M
Dumas, R
Citation: L. Ichay et al., Hematuria revealing primary hyperparathyroidism., ARCH PED, 6(2), 1999, pp. 182-185
Authors:
Aimonetti, JM
Morin, D
Schmied, A
Vedel, JP
Pagni, S
Citation: Jm. Aimonetti et al., Proprioceptive control of wrist extensor motor units in humans: dependenceon handedness, SOMAT MOT R, 16(1), 1999, pp. 11-29
Authors:
Reymond, F
Steyaert, G
Carrupt, PA
Morin, D
Tillement, JP
Girault, HH
Testa, B
Citation: F. Reymond et al., The pH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis, PHARM RES, 16(5), 1999, pp. 616-624
Authors:
Morin, D
Citation: D. Morin, Tips for welders, WELDING J, 1999, pp. 8-8
Authors:
Spedding, M
Tillement, JP
Morin, D
Le Ridant, A
Citation: M. Spedding et al., Mitochondria as targets for drugs: effects of trimetazidine, THERAPIE, 54(5), 1999, pp. 627-635
Authors:
Morin, D
Murphy, KR
Larocque, A
Citation: D. Morin et al., The relationship between performance appraisal and indulgence in the evaluation process, RELAT IND, 54(4), 1999, pp. 694-726
Authors:
Ochoa, JG
Foucher, S
Poncin, S
Morin, D
Wild, G
Citation: Jg. Ochoa et al., Bioleaching of mineral ores in a suspended solid bubble column: hydrodynamics, mass transfer and reaction aspects, CHEM ENG SC, 54(15-16), 1999, pp. 3197-3205
Authors:
d'Hugues, P
Cezac, P
Battaglia, F
Morin, D
Citation: P. D'Hugues et al., Bioleaching of a cobaltiferous pyrite at 20% solids: a continuous laboratory-scale study, PROCESS MET, 9, 1999, pp. 167-176
Authors:
Ochoa, JG
Poncin, S
Morin, D
Wild, G
Citation: Jg. Ochoa et al., Bioleaching of mineral ores in a suspended solid bubble column, PROCESS MET, 9, 1999, pp. 631-641
Authors:
Gomory, F
Bettinelli, D
Gherardi, L
Crotti, G
Morin, D
Citation: F. Gomory et al., Contactless measurement of hysteretic transport AC losses in multifilamentary BiSrCaCuO-2223/Ag tapes, PHYSICA C, 308(3-4), 1998, pp. 203-214
Authors:
Morin, D
Cotte, N
Balestre, MN
Mouillac, B
Manning, M
Breton, C
Barberis, C
Citation: D. Morin et al., The D136A mutation of the V-2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities, FEBS LETTER, 441(3), 1998, pp. 470-475
Authors:
Morin, D
Cotte, N
Phalipou, S
Balestre, MN
Ala, Y
Sabatier, N
Jard, S
Vargas, R
Antignac, C
Dechaux, M
Arthus, M
Lonergan, M
Turner, MS
Bichet, DG
Hendy, GN
Alonso, G
Manning, M
Hibert, M
Mouillac, B
Barberis, C
Citation: D. Morin et al., The vasopressin V2 receptor: molecular basis of the nephrogenic diabetes insipidus and identification of residues responsible for binding selectivity, HYDRATION THROUGHOUT LIFE, 1998, pp. 215-221